Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arrowsmith, J. Phase II failures: 2008–2010. Nat Rev Drug Discov 10, 328–329 (2011). https://doi.org/10.1038/nrd3439
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3439
- Springer Nature Limited
This article is cited by
-
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs
Translational Psychiatry (2023)
-
An effector index to predict target genes at GWAS loci
Human Genetics (2022)
-
“Digital biomarkers” in preclinical heart failure models — a further step towards improved translational research
Heart Failure Reviews (2022)